ABSTRACT
INTRODCUTION

Background
In its 2015 ruling Carter v Canada, the Supreme Court of Canada (SCC) struck down the criminal prohibition on assisting individuals in suicide, if physicians deemed such individuals to be competent adults with a "grievous and irremediable medical condition" causing "enduring suffering intolerable to the individual." [1] The SCC suspended the ruling for one year to provide the Canadian federal government with time to develop a legislative framework for medical assistance in dying (MAID). [2] In June 2016, the federal government passed Bill C-14, which decriminalized assisted dying for capable patients with intolerable suffering for whom death was "reasonably foreseeable." [3] Study rationale
Although Bill C-14 legislated eligibility criteria under which patients could receive MAID, the law did not provide clinicians or organizations with guidance regarding the technical aspects of providing MAID, including fundamental issues as whether it should be in the form of assisted suicide (in which a person self-administers a lethal medication prescribed and provided by a health care professional) or euthanasia (in which a person receives a lethal dose of medication at the hands of a health care professional). As a result, Canadian clinicians and organizations have struggled with many practical questions about providing MAID, including:
1. Should MAID be provided in the form of assisted suicide, euthanasia, or a combination of the two?
2. Which pharmaceuticals, doses and routes of administration should be used for MAID?
3. Should MAID provision take place in the community, institutional settings, or in dedicated, expert centres?
4. What is the appropriate role, scope of practice, and training of MAID providers?
5. How should patients' families be involved in the provision of MAID?
6. How can organ donation be incorporated into the provision of MAID?
Given concerns about variation in consistency and quality of MAID, including the possibility of technical problems with medication administration, and the potentially high impact of the practice upon patients, families and health care providers, there is an urgent need to develop an evidence base to guide the provision of MAID. [5, 6] providing MAID. [4, 5] Therefore, we propose a scoping review on the provision of MAID from all jurisdictions where assisted dying is legal, in order to determine the range, scope, and content of the existing medical literature on the provision of MAID in consenting adults, and to identify evidence gaps to guide future research in MAID care.
Study Objectives
1)
To describe the existing medical literature on the provision of MAID 2) To summarize the existing medical literature and provide an overview of the technical aspects of MAID provision (including pharmaceuticals and procedures; location of provision;
the role, scope of practice, and training of health care professionals; role of patients' families; rates of adverse events; and integration of MAID organ donation)
3) To identify evidence gaps to guide future research in MAID
METHODS AND ANALYSIS
The methods of in this scoping review protocol are based upon those described in the Joanna Briggs Institute Reviewer's Manual. [7] Inclusion and exclusion criteria
As opposed to a systematic review, the selection of studies and reports in a scoping review is an iterative process, and inclusion and exclusion criteria may undergo revision as the review progresses, taking into account findings which emerge during the course of the review. [7] [8] [9] In this protocol, we outline our initial inclusion and exclusion criteria (Table 1) , while any changes made during the course of the review will be described in the final review manuscript.
Types of participants
We will include reports which include adult (age>18) patients who have provided informed consent for MAID in the form of either assisted suicide or euthanasia, for any reason, or are intended for use with such patients. We will include studies where patients have provided informed consent to MAID in advance of the development of incapacity (eg. advanced directives 
Types of interventions
We will include reports which describe the provision of MAID by either assisted suicide or euthanasia, using any method, in any location. We will exclude reports where patients receive assisted suicide or euthanasia without the involvement of a health care professional such as a physician, nurse, or pharmacist; reports which solely describe the assessment of patient eligibility for MAID; and descriptions of public or healthcare provider opinions about about acceptability or ethics MAID. We will also exclude reports describing other end-of-life practices, including withholding or withdrawing of life-sustaining treatment; palliative sedation, or unintentional hastening of death via medications for symptom management (eg. the doctrine of double effect), unless such reports also include separate descriptions of MAID.
Types of sources
We will include technical reports, institutional policies, practice surveys, clinical practice guidelines, and clinical studies (case report, observational studies or clinical trials). Opinion pieces/letters will be excluded. We will impose no restrictions based upon methodological quality, study location, language, or publication date. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Search strategy
We will conduct systematic searches of multiple databases, including MEDLINE, 
Selection Process
Report eligibility will be determined in two stages: first by screening of titles and abstracts, and secondly by full-text screening. At each stage, two investigators (CS, SO) will pilot-test the screening and eligibility forms on the first 10 reports in order to ensure consistent independently review each report for inclusion eligibility in the review. In the event of disagreement over report eligibility which cannot be resolved by discussion between the two investigators, a third investigator will make the final determination of eligibility. To provide a measure of the consistency of application of the inclusion and exclusion criteria at each stage, a weighted kappa statistic will be calculated as a measure of inter-rater reliability.
[10]
If during the course of the review, the investigators believe that a change to the inclusion or exclusion criteria is warranted, this will be discussed with the entire investigative team for review and approval, to ensure that the proposed changes are consisted with the study objectives. Any such changes will be clearly delineated in the final review manuscript in order to ensure methodological transparency.
Extraction of results
Data will be collected by two investigators (CS, SO) using structured data extraction
forms. An initial set of data items is listed below (Table 2) , however the final set of data items to be collected may change as review progresses, based upon the data contained in the included reports. The two investigators will independently chart data from the first five included reports to pilot-test the data extraction form and to ensure consistent data collection. As the review progresses, the investigators will discuss and collate results, and consider updating the data charting forms to ensure that the collected data is consistent with the review's objectives. The initial data collection forms will collect data related to three major concepts: report characteristics; methods of MAID provision (medications, locations, participants); and MAID outcomes. 
Presentation of results
We will organize the collected data according to the three major concepts listed above (report characteristics; MAID provision; and MAID outcomes). We will summarize the report We will summarize data about the provision of MAID and about MAID outcomes in tables categorized as follows: pharmaceuticals and equipment; location of provision; personnel; documentation; and aftercare, with accompanying descriptive statistics of frequency or proportion for categorical data, and mean and standard deviation or median and interquartile range for continuous data. The tables will summarize the collected data, for assisted suicide and euthanasia separately, where appropriate (eg. pharmaceuticals, personnel). We will summarize the tabulated data and provide a description of their relevance to the provision of MAID in Canada, identify knowledge gaps, and formulate topics for future research.
ETHICS AND DISSEMINATION
This scoping review will provide a comprehensive description of the range and scope of the existing literature on the provision of MAID, and a summary of the technical aspects of providing MAID. We will describe the relevance of the existing literature to the provision of MAID in Canada, and identify knowledge gaps and topics for future research. The results of the review will be submitted for presentation as a conference abstract, and publication in a peerreviewed journal. 
AUTHOR'S CONTRIBUTIONS
SO conceived the idea for the project and developed the initial draft of the manuscript. All authors developed the review methodology and edited and revised the manuscript for essential content and formatting details, and approved the final version of the manuscript for submission. SO and CS will conduct the data collection, data extraction for the review. All authors will contribute to the analysis of the review data. 
Methods and analysis
We will search electronic databases (MEDLINE, EMBASE, CINAHL, CENTRAL, PsycINFO), dementia). We will exclude reports in which patients receive involuntary euthanasia (eg. capital punishment). Two independent investigators will screen and select retrieved reports using pilottested screening and eligibility forms, and collect data using standardized data collection forms.
We will summarize extracted data in tabular format with accompanying descriptive statistics and use narrative format to describe their clinical relevance, identify knowledge gaps, and suggest topics for future research.
Ethics and dissemination
This scoping review will map the range and scope of the existing literature on the provision of MAID in jurisdictions where the practice has been decriminalized. The review will be disseminated through conference presentations and publication in a peer-reviewed journal.
These results will be useful to clinicians, policy makers, and researchers involved with MAID. 
Strengths and limitations of this study
• This will be the first scoping literature review on the provision of medical assistance in dying
• The search strategy includes a comprehensive and systematic search of five electronic databases, conference proceedings, clinical trial registries, and grey literature from jurisdictions where medical assistance in dying has been decriminalized
• Although the study will provide a descriptive overview of how medical assistance in dying may be provided, no formal assessment of the quality of evidence for any given approach will be conducted
• Though this review will not provide recommendations for how to provide medical assistance in dying, an overview of current practices and knowledge gaps may still inform clinicians, policy makers, and researchers working in this area Therefore, we propose a scoping review on the provision of MAID from all jurisdictions where medically assisted dying is not illegal, in order to determine the range, scope, and content of the existing medical literature on the provision of MAID in consenting adults.
Study Objectives
1) To describe the existing medical literature on the provision of MAID
2) To summarize the existing medical literature and provide an overview of the technical aspects of MAID provision (including pharmaceuticals and procedures; location of provision; the role, scope of practice, and training of health care professionals; role of patients' families; rates of adverse events)
METHODS AND ANALYSIS
The methods of this scoping review protocol are based upon those described in the Joanna Briggs Institute Reviewer's Manual. [7] Inclusion and exclusion criteria
Types of participants
We will include reports which include adult (age>18) patients who have provided informed consent for MAID in the form of either assisted suicide or euthanasia, for any reason, or are intended for use with such patients. We will include studies where patients have provided informed consent to MAID in advance of the development of incapacity (e.g. advanced directives for MAID), but exclude reports in which patients receive euthanasia without having provided informed consent (e.g. execution). 
Types of interventions
We will include reports which describe the provision of MAID by either assisted suicide or euthanasia, using any method, in any location. We will exclude reports where patients receive assisted suicide or euthanasia without the involvement of a health care professional such as a physician, nurse, or pharmacist; reports which solely describe the assessment of patient eligibility for MAID; and descriptions of public or healthcare provider opinions about about acceptability or ethics of MAID. We will also exclude reports describing other end-of-life practices, including withholding or withdrawing of life-sustaining treatment; palliative sedation, or unintentional hastening of death via medications for symptom management (e.g. the doctrine of double effect), unless such reports also include separate descriptions of MAID.
Types of sources
We will include technical reports, institutional policies, practice surveys, clinical practice guidelines, and clinical studies (case reports, observational studies or clinical trials). Opinion pieces/letters will be excluded. We will impose no restrictions based upon methodological quality, study location, language, or publication date. 
Search strategy
Selection process
Report eligibility will be determined in two stages: first by screening of titles and abstracts, and secondly by full-text screening. Two investigators (CS, SO) will pilot-test the screening and eligibility forms on the first 100 abstracts and the first 10 full-text reports in order to ensure consistent application of inclusion and exclusion criteria at each stage. Following pilottesting and completion of any necessary modifications to the screening and eligibility forms, the same two investigators will independently review each report's eligibility for inclusion in the review. In the event of disagreement over report eligibility which cannot be resolved by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 If during the course of the review, the investigators believe that a change to the inclusion or exclusion criteria is warranted, this will be discussed with the entire investigative team for review and approval, to ensure that the proposed changes are consistent with the study objectives. Any such changes will be clearly delineated in the final review manuscript in order to ensure methodological transparency.
Extraction of results
forms. An initial set of data items is listed below (Table 2) , however the final set of data items to be collected may change as review progresses, based upon the data contained in the included reports. The two investigators will independently chart data from the first five included reports to pilot-test the data extraction form, thereby ensuring consistent and comprehensive data collection. Following pilot testing and, if necessary, modification of the data extraction forms, the two investigators will continue with duplicate data extraction. As the review progresses, the investigators will compare and discuss the extracted data, and consider updating the data extraction forms to ensure that the collected data is consistent with the review's objectives. The initial data collection forms will collect data related to three major concepts: report characteristics; methods of MAID provision (medications, locations, participants); and MAID outcomes. 
Presentation of results
We will organize the collected data according to the three major concepts listed above (report characteristics; MAID provision; and MAID outcomes). We will summarize the report characteristics, including date of publication, publication type, and geographic origin of publication in a We will summarize data about the provision of MAID and about MAID outcomes in tables categorized as follows: pharmaceuticals and equipment; location of provision; personnel; documentation; and aftercare, with accompanying descriptive statistics of frequency or proportion for categorical data, and mean and standard deviation or median and interquartile range for continuous data. The tables will summarize the collected data, for assisted suicide and euthanasia separately, where appropriate (e.g. pharmaceuticals, personnel). We will synthesize this information in narrative format, describing the type and range of the available evidence and its relevance to the five questions described in the study rationale, above. Though a formal appraisal of the quality (certainty) of the evidence is not routinely conducted in a scoping review, [7] we will comment upon the reliability and trustworthiness of the available evidence, based upon the methods of each report and the consistency, or lack of consistency, of results between reports. We will summarize the data's potential relevance to the provision of MAID in Canada, as compared to other clinical and legal contexts. In doing so, we will identify knowledge gaps and formulate topics for future research.
ETHICS AND DISSEMINATION
AUTHOR'S CONTRIBUTIONS
SO conceived the idea for the project and developed the initial draft of the manuscript. All authors developed the review methodology and edited and revised the manuscript for essential content and formatting details, and approved the final version of the manuscript for submission. SO and CS will conduct the searches, screening, data extraction, and data summaries for the review. All authors will contribute to the analysis of the review data.
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